Gene · 3783
Papers2,742
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
601 to 620 of 2,742
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Epigenetic Alterations in Inborn Errors of Immunity. | J Clin Med | 2022 | 35268351 | PubTator, text mining | PubMed |
| Imaging Kv1.3 Expressing Memory T Cells as a Marker of Immunotherapy Response. | Cancers (Basel) | 2022 | 35267526 | PubTator, text mining | PubMed |
| Stem Cell Based Models in Congenital Hyperinsulinism - Perspective on Practicalities and Possibilities. | Front Endocrinol (Lausanne) | 2022 | 35250887 | PubTator, text mining | PubMed |
| Multilayer control of cardiac electrophysiology by microRNAs. | J Mol Cell Cardiol | 2022 | 35247375 | PubTator, text mining | PubMed |
| Effects of Androgen Excess-Related Metabolic Disturbances on Granulosa Cell Function and Follicular Development. | Front Endocrinol (Lausanne) | 2022 | 35237237 | PubTator, text mining | PubMed |
| Ion Channel Dysfunction in Astrocytes in Neurodegenerative Diseases. | Front Physiol | 2022 | 35222082 | PubTator, text mining | PubMed |
| The Biphasic Effect of Retinoic Acid Signaling Pathway on the Biased Differentiation of Atrial-like and Sinoatrial Node-like Cells from hiPSC. | Int J Stem Cells | 2022 | 35220280 | PubTator, text mining | PubMed |
| Long-term adjuvant administration of temozolomide impacts serum ions concentration in high-grade glioma. | Chin Neurosurg J | 2022 | 35216639 | PubTator, text mining | PubMed |
| Deciphering the Interactions of SARS-CoV-2 Proteins with Human Ion Channels Using Machine-Learning-Based Methods. | Pathogens | 2022 | 35215201 | PubTator, text mining | PubMed |
| Preclinical Identification of Sulfasalazine's Therapeutic Potential for Suppressing Colorectal Cancer Stemness and Metastasis through Targeting KRAS/MMP7/CD44 Signaling. | Biomedicines | 2022 | 35203586 | PubTator, text mining | PubMed |
| The Function of Ion Channels and Membrane Potential in Red Blood Cells: Toward a Systematic Analysis of the Erythroid Channelome. | Front Physiol | 2022 | 35177994 | PubTator, text mining | PubMed |
| Pharmacological modulation of Kv1.3 potassium channel selectively triggers pathological B lymphocyte apoptosis in vivo in a genetic CLL model. | J Exp Clin Cancer Res | 2022 | 35172855 | PubTator, text mining | PubMed |
| Purinergic signaling is essential for full Psickle activation by hypoxia and by normoxic acid pH in mature human sickle red cells and in vitro-differentiated cultured human sickle reticulocytes. | Pflugers Arch | 2022 | 35169901 | PubTator, text mining | PubMed |
| Airway Delivery of Hydrogel-Encapsulated Niclosamide for the Treatment of Inflammatory Airway Disease. | Int J Mol Sci | 2022 | 35163010 | PubTator, text mining | PubMed |
| The Role of Calcium Signaling in Melanoma. | Int J Mol Sci | 2022 | 35162934 | PubTator, text mining | PubMed |
| Targeting the KCa3.1 channel suppresses diabetes-associated atherosclerosis via the STAT3/CD36 axis. | Diabetes Res Clin Pract | 2022 | 35149165 | PubTator, text mining | PubMed |
| The Challenges of Predicting Drug-Induced QTc Prolongation in Humans. | Toxicol Sci | 2022 | 35148401 | PubTator, text mining | PubMed |
| Pharmacological blockade of KV1.3 channel as a promising treatment in autoimmune diseases. | J Transl Autoimmun | 2022 | 35146402 | PubTator, text mining | PubMed |
| RNA sequencing on muscle biopsy from a 5-week bed rest study reveals the effect of exercise and potential interactions with dorsal root ganglion neurons. | Physiol Rep | 2022 | 35133080 | PubTator, text mining | PubMed |
| The phosphatase of regenerating liver-3 protein (PRL-3) promotes glioma cell invasiveness by interacting with β3 -tubulin. | Bioengineered | 2022 | 35098869 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3783/papers?page=31